Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Method for inactivation and direct RT-qPCR of SARS-CoV-2

Researchers from the University of Edinburgh have been exploring ways to optimize this process further, allowing RT-qPCR to work more efficiently by eliminating one of the key steps.

7 Dec 2021

Study suggests algal polysaccharide may be a promising anti-COVID-19 candidate

Researchers from the Rensselaer Polytechnic Institute have been investigating the potential of rhamnan sulfate as an antiviral agent.

7 Dec 2021

Scientists develop and characterize variant-specific vaccines against SARS-CoV-2

In a recent study conducted at Yale University, USA, scientists have investigated the immunogenicity of mRNA-based coronavirus disease 2019 (COVID-19) vaccine candidates encoding the spike proteins of different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. The findings reveal that the vaccines induce robust immune responses against SARS-CoV-2 variants. The study is currently available on the bioRxiv* preprint server.

6 Dec 2021

An analysis of risk factors and symptom presentation among groups at risk for SARS-CoV-2 infection

The study, published on the pre-print server medRxiv*, analyzed the specific linkages between the COVID-19 patients belonging to the three risk groups with the overall COVID-19 patients and compared symptoms between and within the risk groups.

6 Dec 2021

COVID-19 severity is correlated with T cell receptor repertoire signatures

In a new study published in the bioRxiv* preprint server, researchers found that specific TCR sequences predicted the severity of coronavirus disease 2019 (COVID-19) infection. Additionally, there was evidence of increased CDR3 sequences and changes in k-mer motifs for patients with severe illness.

6 Dec 2021

Simple quantitative framework to understand the pathogenesis of severe COVID-19

Researchers from Los Alamos National Laboratory in the United States developed a model to explain why severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections induce high inflammatory levels.

6 Dec 2021

Omicron variant increases risk of SARS-CoV-2 reinfection

New surveillance data from South Africa published in the medRxiv* preprint server suggests that the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omnicron variant has the potential to escape naturally-acquired immunity. The research indicates people who previously recovered from a coronavirus disease 2019 (COVID-19) are at risk for reinfection with the Omicron variant. The results show that the risk of reinfection is greater with the Omicron variant versus Delta and Beta.

6 Dec 2021

Disparities in maternal mental health during COVID-19

In new research, scientists studied individuals who gave birth during COVID-19. Using propensity score matching (PSM), they matched those identified as either Black or Latinx with those identified as non-Hispanic white on sociodemographic. This recent study published as a preprint on the medRxiv* server attempts to assess the impact of the COVID-19 pandemic on childbirth-related health outcomes in individuals belonging to Black or Latinx minority groups.

6 Dec 2021

SARS-CoV-2 S2 immunization as a pan-coronavirus vaccine approach

A new mouse model suggests that prior HCoV-OC43 S immunity primes neutralising antibody responses to otherwise subimmunogenic SARS-CoV-2 S exposure as well as promotes S2-targeting antibody responses.

6 Dec 2021

Lack of computer access in COVID predicts lower mental health among adolescents

A new study discusses adolescent mental health during the pandemic in association with the availability of digital access through computers to do schoolwork.

6 Dec 2021

Study shows COVID booster shots work

A new study investigates uses seven different COVID-19 vaccines as the third dose to boost immunity in vulnerable patients.

6 Dec 2021

SARS-CoV-2 Delta saliva viral load 15 times that of the wild type

Researchers hypothesize that a higher viral load of SARS-CoV-2 Delta variant in saliva contributes to its high transmissibility.

6 Dec 2021

Hospitalization trends and associated factors for COVID in 2.3 million adults in England

Researchers performed a retrospective cohort study to determine risk factors for hospitalization and mortality rates over time among COVID-19 patients.

6 Dec 2021

SARS-CoV-2 virus-like particles elicit potent neutralizing antibody response in variant challenge

Researchers develop a virus-like particle for SARS-CoV-2 based on the co-expression of the spike, membrane, and envelope structural proteins.

6 Dec 2021

Safety and immunogenicity of SARS-CoV-2 recombinant spike protein vaccine

Researchers have presented the results of phase 1 and phase 2 clinical trials of a SARS-CoV-2 recombinant spike protein vaccine (Abdala).

6 Dec 2021

Colorimetric detection of SARS-CoV-2 viral RNA by an in vitro transcription/translation assay

This work has emphasized the clinical and translational potential of paper-based biosensors.

6 Dec 2021

SARS-CoV-2 immune memory in mRNA vaccine recipients

Researchers measured SARS-CoV-2–specific antibody, memory B cell, and memory T cell responses in a group of healthy subjects who generated primary immune responses to two doses of mRNA vaccine compared to a group of SARS-CoV-2–recovered vaccines.

6 Dec 2021

Forecasting outbreak of SARS-CoV-2 Omicron variant with Tajima's D

A new study argues that that rapid genomic sequence surveillance is absolutely crucial and Tajima D tests should be included to predict future COVID-19 outbreaks.

6 Dec 2021

COVID-19-recovered patients at an increased risk of developing new-onset mental illness

Research suggests that patients who have recovered from COVID-19 were at an increased risk for developing new-onset mental illness.

6 Dec 2021

The link between cytokine storms and cardiovascular problems in COVID-19 patients

New findings may help doctors choose effective COVID-19 treatment regimens for patients with heart complications.

6 Dec 2021

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Method for inactivation and direct RT-qPCR of SARS-CoV-2

Study suggests algal polysaccharide may be a promising anti-COVID-19 candidate

Scientists develop and characterize variant-specific vaccines against SARS-CoV-2

An analysis of risk factors and symptom presentation among groups at risk for SARS-CoV-2 infection

COVID-19 severity is correlated with T cell receptor repertoire signatures

Simple quantitative framework to understand the pathogenesis of severe COVID-19

Omicron variant increases risk of SARS-CoV-2 reinfection

Disparities in maternal mental health during COVID-19

SARS-CoV-2 S2 immunization as a pan-coronavirus vaccine approach

Lack of computer access in COVID predicts lower mental health among adolescents

Study shows COVID booster shots work

SARS-CoV-2 Delta saliva viral load 15 times that of the wild type

Hospitalization trends and associated factors for COVID in 2.3 million adults in England

SARS-CoV-2 virus-like particles elicit potent neutralizing antibody response in variant challenge

Safety and immunogenicity of SARS-CoV-2 recombinant spike protein vaccine

Colorimetric detection of SARS-CoV-2 viral RNA by an in vitro transcription/translation assay

SARS-CoV-2 immune memory in mRNA vaccine recipients

Forecasting outbreak of SARS-CoV-2 Omicron variant with Tajima's D

COVID-19-recovered patients at an increased risk of developing new-onset mental illness

The link between cytokine storms and cardiovascular problems in COVID-19 patients

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Newsletters you may be interested in